OracleBio will be attending the 2019 Annual Meeting of the American Association for Cancer Research (AACR), which takes place from the 29th of March to the 3rd of April in Atlanta, Georgia, USA.
OracleBio will be exhibiting at Booth 4436 from the 31st of March to the 3rd of April and also presenting a poster at the conference (details to follow).
OracleBio offers a range of digital pathology services to support pre-clinical and clinical oncology R&D. Using immunohistochemistry and immunoflourescence techniques, we are able to produce a variety of quantifiable results valuable to oncology research, such as immune cell number, immune cell co-localisation and spatial distribution within the tumor microenvironment. Click here to find out more information about how our services can support your oncology research.
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world. To find out more about the AACR Annual Meeting 2019, please click here.
Lorcan Sherry, OracleBio’s CSO, along with our Senior Project Manager, Mark Anderson, Business Development Manager, Hannah Thomson, and Business Development Assistant, Alison Stewart, will be at Booth 4436 throughout the meeting. If you would like to learn more about OracleBio’s services, or wish to arrange a time to speak with our team during the event, please contact us.
To keep up to date with all OracleBio news and events, follow us on LinkedIn by clicking the button below: